Männedorf, Switzerland, August 11, 2021 - The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2021 on Wednesday, August 18th
Tecan Group AG: Tecan to present at UBS Global Healthcare Virtual Conference
May 21
, 2021 - The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at the UBS Global Healthcare Virtual Conference next week.
UBS Global Healthcare Virtual Conference
Date: 25 May 2021
Presentation and Fireside Chat: 4:00 pm CET
A replay of the webcast will be available after the presentation and will remain available for 30 days.
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instrume
Message :
Required fields Votes cast exclusively through the independent proxy in line with COVID-19 Ordinance 3 of the Swiss government to combat the pandemic Increase in the dividend from CHF 2.20 to CHF 2.30 per share Lukas Braunschweiler, Heinrich Fischer, Oliver Fetzer, Karen Huebscher, Christa Kreuzburg and Daniel R. Marshak re-elected as members of the Board of Directors Lukas Braunschweiler confirmed by shareholders as Chairman of the Board Christa Kreuzburg, Oliver Fetzer and Daniel R. Marshak confirmed as members of the Compensation Committee All proposals relating to compensation approved Männedorf, Switzerland, April 13, 2021 The Annual General